GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bioptik Technology Inc (ROCO:4161) » Definitions » ROE % Adjusted to Book Value

Bioptik Technology (ROCO:4161) ROE % Adjusted to Book Value : 7.14% (As of Dec. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Bioptik Technology ROE % Adjusted to Book Value?

Bioptik Technology's ROE % for the quarter that ended in Dec. 2024 was 12.93%. Bioptik Technology's PB Ratio for the quarter that ended in Dec. 2024 was 1.81. Bioptik Technology's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 was 7.14%.


Bioptik Technology ROE % Adjusted to Book Value Historical Data

The historical data trend for Bioptik Technology's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bioptik Technology ROE % Adjusted to Book Value Chart

Bioptik Technology Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only -4.59 1.63 3.63 5.37 6.01

Bioptik Technology Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.33 3.83 6.21 3.76 7.14

Competitive Comparison of Bioptik Technology's ROE % Adjusted to Book Value

For the Medical Devices subindustry, Bioptik Technology's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bioptik Technology's ROE % Adjusted to Book Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Bioptik Technology's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Bioptik Technology's ROE % Adjusted to Book Value falls into.


;
;

Bioptik Technology ROE % Adjusted to Book Value Calculation

Bioptik Technology's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=10.88% / 1.81
=6.01%

Bioptik Technology's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=12.93% / 1.81
=7.14%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bioptik Technology ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Bioptik Technology's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Bioptik Technology Business Description

Traded in Other Exchanges
N/A
Address
No.188, Zhonghua South Road, Miaoli County, Zhunan, TWN, 35057
Bioptik Technology Inc is a Taiwan-based company engaged in the research, development, production, and sale of medical devices and reagents. The company is also focused on developing skin care products and aims to engage in developing bioenergy, Astaxanthin, and Cellulose Bioethanol. It is involved in the business areas of Home care medical devices, Skincare- Its own brand, Dietary supplement OEM and ODM, Skincare- OEM and ODM, and Biodiesel. In the Home care business area, the company provides Easy Touch blood glucose monitoring, and blood cholesterol and uric acid monitoring systems, as well as its strips.

Bioptik Technology Headlines

No Headlines